TY - JOUR
T1 - Host defenses to Rickettsia rickettsii infection contribute to increased microvascular permeability in human cerebral endothelial cells
AU - Woods, Michael E.
AU - Olano, Juan P.
N1 - Funding Information:
Acknowledgment This work was supported by funding from the United States Army Research and Material Command #DAMD17-02-1-0198 (J.P.O) and the NIH T32 Training Grant in Biodefense AI 060549 (M.E.W.). The authors would also like to acknowledge the W. M. Keck Center for Virus Imaging. Finally, the authors would like to thank Dr. David Walker for his critical evaluation of this work.
PY - 2008/3
Y1 - 2008/3
N2 - Rickettsiae are arthropod-borne intracellular bacterial pathogens that primarily infect the microvascular endothelium leading to systemic spread of the organisms and the major pathophysiological effect, increased microvascular permeability, and edema in vital organs such as the lung and brain. Much work has been done on mechanisms of immunity to rickettsiae, as well as the responses of endothelial cells to rickettsial invasion. However, to date, no one has described the mechanisms of increased microvascular permeability during acute rickettsiosis. We sought to establish an in vitro model of human endothelial-target rickettsial infection using the etiological agent of Rocky Mountain spotted fever, Rickettsia rickettsii, and human cerebral microvascular endothelial cells. Endothelial cells infected with R. rickettsii exhibited a dose-dependent decrease in trans-endothelial electrical resistance, which translates into increased monolayer permeability. Additionally, we showed that the addition of pro-inflammatory stimuli essential to rickettsial immunity dramatically enhanced this effect. This increase in permeability correlates with dissociation of adherens junctions between endothelial cells and is not dependent on the presence of nitric oxide. Taken together, these results demonstrate for the first time that increased microvascular permeability associated with rickettsial infection is partly attributable to intracellular rickettsiae and partly attributable to the immune defenses that have evolved to protect the host from rickettsial spread.
AB - Rickettsiae are arthropod-borne intracellular bacterial pathogens that primarily infect the microvascular endothelium leading to systemic spread of the organisms and the major pathophysiological effect, increased microvascular permeability, and edema in vital organs such as the lung and brain. Much work has been done on mechanisms of immunity to rickettsiae, as well as the responses of endothelial cells to rickettsial invasion. However, to date, no one has described the mechanisms of increased microvascular permeability during acute rickettsiosis. We sought to establish an in vitro model of human endothelial-target rickettsial infection using the etiological agent of Rocky Mountain spotted fever, Rickettsia rickettsii, and human cerebral microvascular endothelial cells. Endothelial cells infected with R. rickettsii exhibited a dose-dependent decrease in trans-endothelial electrical resistance, which translates into increased monolayer permeability. Additionally, we showed that the addition of pro-inflammatory stimuli essential to rickettsial immunity dramatically enhanced this effect. This increase in permeability correlates with dissociation of adherens junctions between endothelial cells and is not dependent on the presence of nitric oxide. Taken together, these results demonstrate for the first time that increased microvascular permeability associated with rickettsial infection is partly attributable to intracellular rickettsiae and partly attributable to the immune defenses that have evolved to protect the host from rickettsial spread.
KW - Bacterial infection
KW - Cytokines
KW - Microvascular permeability
KW - Nitric oxide
KW - Rickettsiae
UR - http://www.scopus.com/inward/record.url?scp=40149106317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40149106317&partnerID=8YFLogxK
U2 - 10.1007/s10875-007-9140-9
DO - 10.1007/s10875-007-9140-9
M3 - Article
C2 - 17957455
AN - SCOPUS:40149106317
SN - 0271-9142
VL - 28
SP - 174
EP - 185
JO - Journal of Clinical Immunology
JF - Journal of Clinical Immunology
IS - 2
ER -